Acumen Pharmaceuticals (ABOS) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
ABOS is expected to report earnings to rise 6.38% to -36 cents per share on November 12
Q3'24
Est.
$-0.36
Q2'24
Missed
by $0.07
Q1'24
Beat
by $0.01
Q4'23
Missed
by $0.11
Q3'23
Beat
by $0.02
The last earnings report on August 13 showed earnings per share of -34 cents, missing the estimate of -27 cents. With 168.30K shares outstanding, the current market capitalization sits at 194.06M.